Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 22, 1999

View Archived Issues

Company Profile: Allelix

The relationship among ERT, cardiovascular disease and cancer

Amylin signs letter of intent for sale of Cabrillo division

Centocor: Q4 1998 highlights

ERT gel available in Canada

Biogen and Inhale enter agreement for pulmonary delivery of Avonex

Glaxo Wellcome issues new R&D pipeline

Activase for acute management of stroke approved in Canada

Noven, Novartis and Vivelle Ventures to join in promoting osteoporosis nasal spray

Alpharma and Ascent enter strategic alliance

Licensing partner sought for development of prohibitin gene-based cancer Rx, Dx

Available for licensing from OMRF: diagnostic and therapeutic agents for spondyloarthropathies

Polyol anti-Helicobacter pylori agents, compositions and use claimed by Takeda

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

SangStat's Thymoglobulin launched in U.S.

Janssen patents structurally distinct gastric prokinetic agents

Peptidomimetic aspartyl protease inhibitors from Pharmacopeia for AD and malaria

Dual 5-HT1A antagonists and 5-HT reuptake inhibitors emerge from research at Vita-Invest

U.S. patent providing improved gene delivery vectors issued to GenVec

Patent covers Millennium process for identifying antimicrobial drug targets

FDA accepts NDA filing for Evacet

Antihypertensive effects of bradykinin agonist FR-190997 evaluated in animals

Renal protective effects of azelnidipine involve inhibition of AGE production

Zeneca seeks European approval for Zomig formulation using OraSolv technology

Liposome initiates phase I clinical trial of TLC-ELL-12

Ceresine shows positive results in phase II trial in stroke patients

FDA permits initiation of GlycoDesign's phase I/II study of GD0039 as chemoprotective agent

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

AVI BioPharma presents data from preclinical study of Resten-NG in restenosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.